KYTO
Overview
Kyto Technology and Life Science, Inc. is a venture capital firm and business development company (BDC) that specializes in startups and early-stage companies in the technology and life science sectors. The firm, which trades under the ticker OTC: KBPH, aims to create a liquid investment vehicle of diversified and vetted start-ups. It typically does not lead investment rounds but follows other accredited investors. Its geographical focus is the United States (over 50%), Canada, and Israel.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AOA Dx | Jun 2021 | Pre Seed | Co-investor |
| Astrocyte Pharmaceuticals Inc. | May 2021 | Series A | Co-investor |
| Light Line Medical | Nov 2020 | Seed | Co-investor |
| infiniDome | Apr 2023 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is KYTO based?
KYTO is headquartered in Los Altos Hills, California, United States.
When was KYTO founded?
KYTO was founded in 1999.
How many portfolio companies does KYTO have?
KYTO has 10 portfolio companies in Caplight's dataset.
What are some companies in KYTO's portfolio?
Portfolio companies visible on Caplight include AOA Dx, Astrocyte Pharmaceuticals Inc., Light Line Medical, infiniDome.
What was KYTO's most recent investment shown here?
KYTO's most recent investment in this portfolio sample was in infiniDome in 2023.
What sectors does KYTO focus on?
KYTO focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Telecommunications & Networking, Frontier & Industrial Tech, Cybersecurity, Mobility, Transportation & Logistics, Enterprise Software, Enterprise Software.
What company stages does KYTO focus on?
KYTO typically invests at the Early stage.
What is KYTO's AUM?
KYTO's assets under management are estimated between $13.1M and $13.1M.